Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...

Jasper is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) as a ...

No one would begrudge Kathy Oliver if, even for a moment, she felt a little sorry for herself. But self-pity and pessimism just aren’t part of her character. “You’ve got to have a positive attitude, ...

ALL patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three ...